We've found 842 total results

Dual JAK1/TYK2 Inhibitor for Cicatricial Alopecia

Alopecia could be subdivided into two main groups of diseases: non-scarring alopecia, such as male pattern baldness, or alopecia areata (AA), in which hair follicles are preserved, yet quiescent, and scarring alopecia, also known as cicatricial alopecia (CA), in which h...

Age: 18 years - 66+

Gender: All

Neurocognition After Perturbed Sleep

Individuals with schizophrenia display a wide range of neurocognitive difficulties resulting in functional impairment and disability. Extensive evidence indicates insomnia and sleep disturbances play a substantial role in degrading cognitive functioning. However, the pu...

Age: 18 - 50 years

Gender: All

Investigation of the Pharmacokinetic Profile of Nanoemulsion CBD

The goal of the current study is to evaluate the bioavaibiltiy of nanoemulsion CBD in normal healthy Individuals. This is an open cross-over design study in healthy individuals to assess the safety and pharmacokinetic (PK) effects of nanoemulsion cannabidiol.

Age: 18 - 65 years

Gender: All

Dupilumab_Metastatic NSCLC

This is an Phase Ib/2 study, single arm, single cohort study to determine the safety and tolerability of Dupilumab with PD-(L)1 blockade for patients with relapsed/refractory metastatic NSCLC. For Phase 2, to determine the effect of adding IL-4Ra blockade to PD-(L)1...

Age: 18 years - 66+

Gender: All

Telehealth Referral to Improve Outcomes

Emergency patients often have uncontrolled asymptomatic hypertension upon discharge from the emergency department. This 3-arm randomized controlled trial will evaluate the impact of nurse telehealth encounters and remote patient monitoring, using a software called Vital...

Age: 18 years - 66+

Gender: All

Telehealth Referral to Improve Outcomes

Emergency patients often have uncontrolled asymptomatic hypertension upon discharge from the emergency department. This 3-arm randomized controlled trial will evaluate the impact of nurse telehealth encounters and remote patient monitoring, using a software called V...

Age: 18 years - 66+

Gender: All

ACTIV-5 / Big Effect Trial (BET-C) for the Treatment of COVID-19

This is a platform trial to conduct a series of randomized, double-blind, placebo-controlled trials using common assessments and endpoints in hospitalized adults diagnosed with COVID-19. BET is a proof-of-concept study with the intent of identifying promising treatm...

Age: 18 years - 66+

Gender: All

Dupilumab in the Treatment of Keloids

This study is a prospective, randomized, double blind, placebo-controlled clinical trial. The study will include a total of 44 subjects with clinically measurable keloid lesions. At least 50% of subjects (at least 22 out of the 44 subjects) will also have documented dia...

Age: 18 years - 66+

Gender: All